3 active not recruiting, 3 completed, 1 withdrawn. 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Active not recruiting 3, Completed 3, Withdrawn 1 |
Follow Prostate Carcinoma: new trials by email Literature Review of Prostate Carcinoma trials Research Report on Prostate Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations ATV-1601, ATV-1601 + Fulvestrant - Advanced Solid Tumors, Breast Cancer | Phase 1 | Active not recruiting | Atavistik Bio, Inc | 134 | 2025-07-29 | 2026-08-07 |
| Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer Bendamustine, Biopsy, Biospecimen Collection - Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2025-04-15 | 2025-04-01 | |
| Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Prostate Gland, Prostate Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2020-09-09 | 2026-08-20 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors XmAb®22841, Pembrolizumab (Keytruda®) - Melanoma, Cervical Carcinoma | Phase 1 | Completed | Xencor, Inc. | 78 | 2019-05-29 | 2023-03-30 |
| Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants Selenium, Placebo, Laboratory Biomarker Analysis - No Evidence of Disease, Prostate Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 66 | 2011-11-01 | 2014-11-26 |
| Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy Laboratory Biomarker Analysis, Pharmacological Study, Veliparib - Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier | Phase 1 | Completed | National Cancer Institute (NCI) | 98 | 2009-04-20 | 2018-06-29 |
Prostatic Neoplasms (7) · Breast Neoplasms (3) · Ovarian Neoplasms (3) · Pancreatic Neoplasms (3) · Triple Negative Breast Neoplasms (3) · Uterine Cervical Neoplasms (3) · Anus Neoplasms (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Transitional Cell (2) · Cholangiocarcinoma (2) · Colorectal Neoplasms (2) · Endometrial Neoplasms (2) · Fallopian Tube Neoplasms (2) · Stomach Neoplasms (2) · Uterine Neoplasms (2)
Genital Diseases (7) · Genital Diseases, Male (7) · Genital Neoplasms, Male (7) · Male Urogenital Diseases (7) · Prostatic Diseases (7) · Urogenital Diseases (7) · Neoplasms (6) · Neoplasms by Site (6) · Urogenital Neoplasms (6) · Adnexal Diseases (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases, Female (4)
FAPI-46 (2) · Magnetic Resonance Spectroscopy (2) · Bendamustine Hydrochloride (1) · Biopsy (1) · Bridge Therapy (1) · Cyclophosphamide (1) · Fluorodeoxyglucose F18 (1) · Fulvestrant (1) · Leukapheresis (1) · Phantoms, Imaging (1) · Selenium (1) · Specimen Handling (1) · X-Rays (1) · fludarabine (1) · pembrolizumab (1)
Jonsson Comprehensive Cancer Center (2) · National Cancer Institute (NCI) (2) · Atavistik Bio, Inc (1) · Fred Hutchinson Cancer Center (1) · Xencor, Inc. (1)
United States (7) · France (1) · Singapore (1) · Spain (1)
Jeremie Calais (2) · Benjamin Thompson, MD, PhD (1) · Michael Schweizer (1) · Raymond Bergan (1) · Shannon Puhalla (1)
N01CN35157 (1), P30CA047904 (1), P30CA060553 (1), U01CA062505 (1), U01CA099168 (1), U01CA132194 (1), UM1CA186690 (1), UM1CA186716 (1), UM1CA186717 (1)